Mohamad Mohty
Mohamad Mohty
Jiasheng Wang
Jiasheng Wang
Deep learning (DL), a subfield of machine learning, has made remarkable strides across various aspects of medicine. This review examines DL's applications in hematology, spanning from molecular insights to patient care. The review begins by...
Pathophysiology and Treatments of Complications of Waldenström's Macroglobulinemia [0.03%]
瓦尔登斯特伦巨球蛋白血症的并发症病理生理及治疗
Nikhil Patel,Samer Al Hadidi,Sarvari Yellapragada
Nikhil Patel
Waldenstrom's macroglobulinemia (WM) or lymphoplasmacytic lymphoma is a B-cell malignancy characterized by lymphoplasmacytic cells in the bone marrow that secrete high amounts of immunoglobulin (Ig) M. The large pentameric structure of IgM ...
Prophylactic Cranial Irradiation prior to HCT for Acute Lymphoblastic Leukemia: To Boost or Not To Boost [0.03%]
急性淋巴细胞白血病移植前颅脑预防照射需加量吗？
Khalid Halahleh,Mohammad S Makoseh,Ayat M Taqash et al.
Khalid Halahleh et al.
Background: Total body irradiation (TBI) with or without cranial radiation boost (CRB) is an integral component of conditioning prior to allogeneic hematopoietic cell transplantation (allo-HCT) in acute lymphoblastic leuk...
Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital Setting [0.03%]
急性髓系白血病患者在社区专业医院和非专业医院治疗的结果决定因素
Minoo Battiwalla,Ju-Hsien Chao,Tonya Cox et al.
Minoo Battiwalla et al.
The treatment setting influences acute myeloid leukemia (AML) outcomes. Most cancer patients receive care in the community, yet few studies have evaluated the effectiveness of clinical programs outside of academic or National Cancer Institu...
Daratumumab-Based Therapeutic Approaches and Clinical Outcomes in Multiple Myeloma and other Plasma Cell Dyscrasias: Insights from a Nationwide Real-World Chart Review Study [0.03%]
达雷妥尤单抗为基础的治疗在多发性骨髓瘤及其他浆细胞异常疾病中的临床疗效：全国范围真实世界研究分析
Allison C Y Tso,Wee Joo Chng,Yeow Tee Goh et al.
Allison C Y Tso et al.
Singapore leads Southeast Asia in the routine use of daratumumab for multiple myeloma and other plasma cell dyscrasias. This retrospective review analyzed 112 patients who received daratumumab between 2012 and 2020. Tolerability, and effica...
Andrew P Jallouk,Salyka Sengsayadeth,Bipin N Savani et al.
Andrew P Jallouk et al.
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma [0.03%]
意义未明单克隆免疫球蛋白血症及冒烟型多发性骨髓瘤患者的个体心理影响
Tanvi H Patel,Ramya Bachu,Trilok Shrivastava et al.
Tanvi H Patel et al.
In our study of 246 newly diagnosed individuals with MGUS or SMM (115 MGUS, 131 SMM), we found that 19% reported anxiety, with no significant difference between the MGUS and SMM groups (22% vs. 17%). Those with a history of psychiatric diso...
The acceptability of using wearable electronic devices to monitor physical activity of patients with Multiple Myeloma undergoing treatment: a systematic review [0.03%]
多发性骨髓瘤患者治疗期间使用可穿戴电子设备监测身体活动的接受度：系统评价
Tommy Brown,Ann Muls,Charlotte Pawlyn et al.
Tommy Brown et al.
Introduction: Multiple myeloma (MM) is diagnosed in 6,000 people in the UK yearly. A performance status measure, based on the patients' reported level of physical activity, is used to assess patients' fitness for treatmen...
SARS-CoV2 is not just infection but a culprit of donor graft failure post-allogeneic stem cell transplant [0.03%]
SARS-CoV2 不仅是感染 而且是allo-HSCT后供者移植物功能衰竭的元凶
Yoojin Park,Silvia Park,Wichai Chinratanalab et al.
Yoojin Park et al.